The SDNA whole saliva collection device has been engineered to lead the saliva collection market in molecular diagnostic applications.
With over 20 million collection devices manufactured and distributed worldwide this innovative and technically-superior biosample collection device has been engineered to reduce self-collection error, is 100% bacteriostatic, and consistently delivers the highest quality, protected and preserved, saliva samples for testing.
The SDNA-1000 offers single device integration for both DNA and Viral RNA applications. Spectrum’s CV3 patented blue preservation chemistry preserves both DNA and viral RNA samples during transport delivering 100% inactivation of the live virus while suspending and stabilizing RNA transcripts for sensitive and specific analysis.
The SDNA-1000’s intuitive design and minimal steps are a welcomed answer for those offering direct-to-patient diagnostic testing or any team that may have experienced clinical study or project failures due to sample self-collection errors in the past.
The SDNA saliva collection device additionally offers long-term stability and ships with verified, unique barcode serialization for biosample physical and digital chain-of-custody. Additionally, customized packaging, kitting, and fulfillment options are available to solve any special project or testing workflow requirements.
For many, choosing the wrong saliva collection device has introduced and often increased critical failure points. Spectrum’s new and technically-superior saliva collection device is the answer your teams and projects have been waiting for.
The first saliva collection device to be authorized for COVID-19 testing, the SDNA-1000 was shown to be a robust source of viral RNA and proven to deliver a more accurate and sensitive testing sample when compared to traditional swabbing.